The Trend of Four Consultation Models in Four Specialties at Four Tertiary Care Hospitals

November 2021 in “ World Family Medicine Journal /Middle East Journal of Family Medicine ”

Hamza Mohammad Abdulghani, Kamran Sattar, S. M. M. Karim, Tauseef Ahmad, Ashfaq Akram, Rakan Alsalem, Mohammed Alruwaite, Nasser Alkhraiji, Ghanem M. Al-Ghamdi, Anas Alkhulaifi

TLDR Different specialties at different hospitals use various consultation models.

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on mejfm.com →

Discuss this study in the Community →

Research cited in this study

4 / 4 results

research Efficacy of Non-Surgical Treatments for Androgenetic Alopecia: A Systematic Review and Network Meta-Analysis

54 citations, May 2018 in “Journal of The European Academy of Dermatology and Venereology”

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-Analysis

research Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-Analysis

15 citations, January 2018 in “Acta dermato-venereologica”

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

research Low-Level Laser Therapy for the Treatment of Androgenic Alopecia: A Review

41 citations, December 2017 in “Lasers in Medical Science”

Low-Level Laser Therapy (LLLT) is a safe and effective treatment for common hair loss, but more research is needed to find the best power and wavelength for treatment.

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of a Novel Formulation of 5% Minoxidil Topical Foam Versus Placebo in the Treatment of Androgenetic Alopecia in Men

research A Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of a Novel Formulation of 5% Minoxidil Topical Foam Versus Placebo in the Treatment of Androgenetic Alopecia in Men

142 citations, August 2007 in “Journal of The American Academy of Dermatology”

New 5% minoxidil foam effectively promotes hair growth and is safe for use.